Finless Foods

Finless Foods uses synthetic biology to culture fish meat for human consumption, developing cellular agriculture technology that isolates stem cells from fish and cultures them in brewery-like environments into fish fillet products. The company uses indigenous growth media to grow cells and harvest them into fish meat with texture similar to conventional fish. Founded in 2017 and headquartered in New York City, Finless Foods has raised approximately $48M in Series B funding from investors including Hanwha Solutions, Dainichi, At One Ventures, Draper, SOSV, Blue Horizon, Starlight Ventures, and Sustainable Ocean Alliance. The company addresses overfishing, ocean pollution, and mercury contamination concerns associated with conventional seafood by producing fish meat without catching fish, offering a sustainable alternative that can be produced in controlled environments with consistent quality and without environmental contaminants.